BEXIMCO PHARMAGDR Valuation
| R2WA Stock | EUR 0.41 0.00 0.00% |
BEXIMCO PHARMAGDR is overvalued. BEXIMCO PHARMAGDR REGS shows a prevailing Real Value of €0.33 per share. The current price of the firm is €0.41. Our model approximates the value of BEXIMCO PHARMAGDR REGS from reviewing the firm fundamentals such as return on equity of 0.12, and Profit Margin of 0.14 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BEXIMCO PHARMAGDR's price fluctuation is out of control at this time. Calculation of the real value of BEXIMCO PHARMAGDR REGS is based on 3 months time horizon. Increasing BEXIMCO PHARMAGDR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BEXIMCO stock is determined by what a typical buyer is willing to pay for full or partial control of BEXIMCO PHARMAGDR REGS. Since BEXIMCO PHARMAGDR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BEXIMCO Stock. However, BEXIMCO PHARMAGDR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.41 | Real 0.33 | Hype 0.41 |
The real value of BEXIMCO Stock, also known as its intrinsic value, is the underlying worth of BEXIMCO PHARMAGDR REGS Company, which is reflected in its stock price. It is based on BEXIMCO PHARMAGDR's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BEXIMCO PHARMAGDR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BEXIMCO PHARMAGDR REGS helps investors to forecast how BEXIMCO stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BEXIMCO PHARMAGDR more accurately as focusing exclusively on BEXIMCO PHARMAGDR's fundamentals will not take into account other important factors: BEXIMCO PHARMAGDR Total Value Analysis
BEXIMCO PHARMAGDR REGS is at this time anticipated to have takeover price of 0 with market capitalization of 563.15 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BEXIMCO PHARMAGDR fundamentals before making investing decisions based on enterprise value of the companyBEXIMCO PHARMAGDR Asset Utilization
One of the ways to look at asset utilization of BEXIMCO is to check how much profit was generated for every dollar of assets it reports. BEXIMCO PHARMAGDR REGS utilizes its assets nearly 0.0659 percent, getting 0.0659 cents for each euro of assets held by the firm. An expanding asset utilization signifies that the company is being more capable with each euro of assets it shows. Put another way, asset utilization of BEXIMCO PHARMAGDR shows how capable it operates for each euro spent on its assets.BEXIMCO PHARMAGDR Ownership Allocation
BEXIMCO PHARMAGDR holds a total of 446.11 Million outstanding shares. Almost 97.91 percent of BEXIMCO PHARMAGDR outstanding shares are held by general public with 2.09 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BEXIMCO PHARMAGDR's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BEXIMCO PHARMAGDR and how it compares across the competition.
About BEXIMCO PHARMAGDR Valuation
The stock valuation mechanism determines BEXIMCO PHARMAGDR's current worth on a weekly basis. Our valuation model uses a comparative analysis of BEXIMCO PHARMAGDR. We calculate exposure to BEXIMCO PHARMAGDR's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BEXIMCO PHARMAGDR's related companies.Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh. Beximco Pharmaceuticals operates under Drug Manufacturers - Major classification in Germany and traded on Frankfurt Stock Exchange.
8 Steps to conduct BEXIMCO PHARMAGDR's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BEXIMCO PHARMAGDR's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BEXIMCO PHARMAGDR's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BEXIMCO PHARMAGDR's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BEXIMCO PHARMAGDR's revenue streams: Identify BEXIMCO PHARMAGDR's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BEXIMCO PHARMAGDR's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BEXIMCO PHARMAGDR's growth potential: Evaluate BEXIMCO PHARMAGDR's management, business model, and growth potential.
- Determine BEXIMCO PHARMAGDR's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BEXIMCO PHARMAGDR's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for BEXIMCO Stock analysis
When running BEXIMCO PHARMAGDR's price analysis, check to measure BEXIMCO PHARMAGDR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BEXIMCO PHARMAGDR is operating at the current time. Most of BEXIMCO PHARMAGDR's value examination focuses on studying past and present price action to predict the probability of BEXIMCO PHARMAGDR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BEXIMCO PHARMAGDR's price. Additionally, you may evaluate how the addition of BEXIMCO PHARMAGDR to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |